[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group:After reviewing the criteria for entering the study and filling the consent form, patient will receive Tab Linagliptin 5mg(known as Melijent) once a day for 14 days in addition to standard treatment of COVID-19 based on latest national protocol.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: After reviewing the criteria for entering the study and filling the consent form, patient will only receive standard treatment of COVID-19 based on latest national protocol.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1780, "treatment_name": "Linagliptin", "treatment_type": "Metabolic agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]